Samer A. Al’Hadidi, MD, discusses social determinants and resources that can help patients receive chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma.

Saad Z. Usmani, MD, MBA, FACP, discusses how the definition of the transplant-ineligible population for multiple myeloma is evolving while also addressing the challenges of standardizing minimal ...

Sikander Ailawadhi, MD, discusses how the 2024 ASH Annual Meeting’s “Survivorship Burden and Patient Preferences Affecting Treatment Choices Among Multiple Myeloma Patients” study examined real-world ...

Myeloma, or multiple myeloma, is a cancer affecting a particular type of blood cells, called plasma cells. Myeloma is most common in people over 60 and is characterized by the accumulation of ...

Krishnan: Pleasure to be here. My name is Amrita Krishnan, I am the director of the Multiple Myeloma Center at the City of Hope. Mikhael: Dr. Rodriguez? Rodriguez: Absolutely. Thank you for the ...

The Ivy Center for Education is making final preperations to host a workshop geared towards promoting career readiness ...

Set to take place at the UAMS South Central Medical Center, the event will be held Tuesday, January 7 at 1601 West 40th Street. Featured in the session are second year UAMS College of Pharmacy ...

The city of Little Rock and nonprofit The Van are coming together, despite their previous splitting, to help those who may ...

UAMS Dr. Robert Hopkins said it warms his heart ... City officials told KARK 4 News that the warming shelter at the Dunbar Community Center will be open the rest of the week from 6 p.m. to 9 ...

“Smoldering multiple myeloma” (SMM) is a blood and bone marrow disorder which can lead to multiple myeloma, a deadly cancer. Detecting the condition can be a challenge, because those living ...

The Myeloma Institute for Research and Therapy ... at the University of Arkansas for Medical Sciences (UAMS) in Little Rock, Arkansas. The MIRT Supportive Care Program was developed to further ...